Safety Recall: Bic Trading Acropass TBC – Japan CAA

Published by Reclia Safety Desk | June 29, 2026

Recall Information Record

Case Number: 00000035392
Product: Acropass TBC
Brand: Bic Trading
Hazards: Safety Risk
Source: Japan Consumer Affairs Agency (CAA)

WHAT HAPPENED

Bic Trading has announced a recall for its product ‘Acropass TBC’ (product name as listed on the recall notice). The recall was triggered by two issues: the sales name was incorrectly displayed as ‘Acropass Trouble Cure’ instead of the correct ‘Acropass TBC’, and the product labeling included efficacy and effect claims that exceed the scope of its approved indications. This regulatory non-compliance poses a risk of consumer misunderstanding regarding the product’s intended use and benefits.

This matter is significant because mislabeling and unauthorized claims can lead to improper use of the product, potentially affecting consumer safety and trust. The recall is being conducted under the oversight of the Consumer Affairs Agency (CAA) and references information from the Pharmaceuticals and Medical Devices Agency (PMDA). The recall process began on June 10, 2026, and consumers are urged to verify their product against the recall notice.

If you have purchased this product, please take the following steps:

• Check the product packaging for the sales name ‘Acropass TBC’ and verify it matches the correct labeling.
• Discontinue use immediately if you have a product with the incorrect name ‘Acropass Trouble Cure’ or if you suspect unauthorized claims.
• Contact Bic Trading using the contact information provided in the recall notice for instructions on return, refund, or replacement.

AFFECTED BATCHES & TARGET SPECIFICS

– **Target Model / Type:** N/A
– **JAN Barcode:** N/A
– **Affected Serial / Lot Numbers:** N/A
– **Total Units Affected:** N/A

ADDITIONAL REGULATORY NOTES

The recall was initiated due to a mislabeling of the sales name (incorrect: ‘Acropass Trouble Cure’, correct: ‘Acropass TBC’) and display of efficacy/effect claims beyond the approved scope. The recall start date is June 10, 2026. Reference information is provided by PMDA. Management number: 00000035392.

❓ Frequently Asked Questions